Century Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXN
BBA
BIT
Century Capital Management's ALXN Position: Q1 2016 in Review
Century Capital Management sold out of Alexion Pharmaceuticals (ALXN) in Q1 2016, closing a stake of 20,801 shares — an estimated $3.97M sold.
Century Capital Management first reported a position in ALXN in Q2 2013 and held it in 11 quarters. The position peaked at $25.7M in Q1 2014. 520 funds tracked by Wall St. Rank hold ALXN as of Q1 2016.
- Century Capital Management reported no remaining Alexion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
- Century Capital Management sold 20,801 Alexion Pharmaceuticals shares in Q1 2016, an estimated $3.97M.
- Century Capital Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 11 quarters.
- Century Capital Management's Alexion Pharmaceuticals position peaked at $25.7M in Q1 2014.
- 520 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2016.
Based on Century Capital Management's 13F filing for Q1 2016, filed 11 May 2016.